向肺部的互乐金-10 mRNA 脂质纳米颗粒 改善急性肺损伤
bioRxiv : the preprint server for biology
|February 6, 2026
概括
一种使用硫脂纳米颗粒 (sLNP) 的新型肺向mRNA输送系统显示出治疗急性肺损伤 (ALI) 的前景. 这种介素-10mRNA/sLNP疗法在小鼠模型中有效降低了炎症和组织损伤.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 肺部医学 肺部医学
背景情况:
- 急性呼吸困难综合征 (ARDS) 是一种严重的急性肺损伤 (ALI) 形式,死亡率高.
- 目前针对ALI/ARDS的治疗方法缺乏特定的药理疗法.
- 需要有效的治疗策略来管理ALI/ARDS.
研究的目的:
- 开发和评估针对肺部的mRNA-sulfonium脂质纳米颗粒 (mRNA/sLNP) 输送系统,用于ALI治疗.
- 调查ALI小鼠模型中通过sLNP传递的IN-10 (IL-10) mRNA的治疗潜力.
主要方法:
- 为sLNP配方优化硫脂结构.
- 优化 sLNP 的全面描述.
- 将IL-10 mRNA加载到sLNP (IL-10/sLNP) 中.
- 在脂聚糖 (LPS) 诱导的ALI小鼠模型中对IL-10/sLNP的评估.
主要成果:
- 开发的IL-10/sLNP系统在ALI小鼠模型中证明了预防和治疗效果.
- 观察到肺部和全身炎症的显著减弱.
- 实现了肺屏障完整性的恢复和组织损伤的减少.
结论:
- 针对肺部的mRNA/sLNP输送是治疗ALI的可行策略.
- 在临床前的ALI模型中,IL-10/sLNP疗法有效减轻炎症和肺损伤.
- 这种方法有可能为ARDS开发新的药理疗法.
相关概念视频
Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Pleura of the Lungs
7.4K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.4K
Gross Anatomy of the Lungs
4.8K
The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
4.8K
Acute Kidney Injury I: Introduction
768
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
768
Acute Kidney Injury II: Pathophysiology
1.1K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K


